Lab Automation Market: Growth, Size, Share, and Trends

Report Code AST 5764
Published in Dec, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Lab Automation Market by Product (Robotic Arm, Microplate Readers, Workstation, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics, Proteomics, Microbiology), End User (Pharma, Diagnolab, Forensics, Environmental) - Global Forecast to 2029

Overview

The global Lab Automation market is poised for substantial growth, projected to achieve USD 7.71 billion by 2029 from USD 5.85 billion in 2024, with a forecast CAGR of 6.9%. The increasing demand for high-throughput screening is the primary driving force in the lab automation market as it allows laboratories to process large volumes of samples more efficiently in drug discovery and diagnostics. Automated systems are error-free as human intervention will be minimized, thus resulting in accurate results for both clinical and research applications. A shortage of skilled manpower increases the need for minimal supervision solutions that reduce labor costs and enhance efficiency. Further development in robotics, artificial intelligence, and machine learning contributes to the capability of automation. Personalization of medicine, rising R&D investment, regulatory compliance, and cost-effectiveness are other factors contributing to this market's growth.

Lab Automation Market

Attractive Opportunities in the Lab Automation Market

North America

In North America, the Lab Automation market is driven primarily by the rising demand for high-throughput screening, increasing R&D expenditures, and technological innovations.

Lab automation is driven its potential to increase throughput and improve accuracy

Innovations in lab automation include rapid molecular diagnostics, automated testing systems, and AI-driven data analysis to get faster and more accurate results.

North America held the largest market share of 40.5% in 2023.

The lab automation market is supported by an increase in funding by public and private organizations and the development of innovative automated solutions by prominent players.

Global Lab Automation Market Dynamics

DRIVER: Requirement of automation in drug discovery

Lab automation is of utmost importance in drug discovery, as it can simplify complex tasks, improve accuracy, and enhance speed. High-throughput screening can be automated so that thousands of compounds are screened much faster than the conventional methods, leading to a much faster identification of drug candidates. This eliminates human errors, provides uniform results, and improves data management and analysis. It also assists in handling large data sets and streamlines the workflow for faster drug development.

Moreover, target identification and regulatory compliance are also automated; however, at the earlier stages, they still pose bottlenecks. Key companies like Arraylet (UK) and SCIEX (US), employ cutting-edge technologies such as bioprinting and Acoustic Ejection Mass Spectrometry (AEMS), which will optimize drug discovery workflows. The 3D cell models help reduce variability and safety. In organ-on-chip cultures, microfluidics is a vital technology. Together, these are key steps toward far more efficient, yet still robust, automation solutions shortly for drug discovery.

Companies and their Laboratory Automation Technologies for Drug Discovery

  • Arraylet (UK): This firm offers bioprinting technology for protein/compound applications such as antibody discovery.
  • SCIEX (US): This company provides an Echo MS+ system that employs AEMS to sample, as well as analytical measure high speed.

RESTRAINT: Slow adaptation in developing countries

Major limiting factors preventing the developing world from fully utilizing lab automation technologies include financial constraints. The repair and service costs associated with laboratory informatics systems are far higher than the original software acquisition price. Experts state that, in most cases, maintaining IT systems will incur recurring costs that amount to 20-30% of the total cost of ownership because of upgrades and other maintenance activities as the needs change over time. In addition, the costs to train and implement this technology can amount to as high as 15% of the overall cost. This is a definite financial weight for small to medium laboratories.

Apart from the above, the cost-effectiveness of automatic systems is not yet to be determined. The lack of information increases risk aversion among the potential adopters who are then cautious of making large investments without concrete evidence of returns on investment.

The long-run cost-effectiveness of automation in lab settings is, however, not well evidenced; hence the slow introduction of automation in developing markets contributes to the delay of its associated benefits of improved efficiency and productivity.

 

OPPORTUNITY: Growth in pharmaceutical and biotechnology industries

US firms conduct most of the world's R&D in pharmaceuticals and hold the intellectual property rights to most new medicines, according to Pharmaceutical Research and Manufacturers Association. Additionally, the biopharmaceutical industry has developed over 5,000 new medicines worldwide, with ~3,400 compounds currently being studied in the US-more than any other region worldwide

New entrants into this space, India and China included, are developing their pharmaceutical and biotechnology industries. The Indian pharmaceutical industry supplies over 50% of global demand for different vaccines, 40% of generic demand in the US, and 25% of all medicines used in the UK. India constitutes the second largest component of the pharmaceutical and biotech workforce in the world. Moreover, in India, the biotechnology industry consists of about 5,000 companies, and in 2021, the value of the industry was at USD 12 billion. In China, various government programs have been carried out to accelerate the growth of pharmaceutical and biotechnology industries. For instance, the Chinese government has chosen biotechnology as one of the most strategic industries within its 13th Five-Year Plan and the Made in China 2025 program. Under Made in China 2025, the country has set specific five- and ten-year targets for Chinese drug firms. Growth in the pharmaceutical industry in India and China has increased the number of quality control, research, and drug development laboratories, which require lab automation to get rapid and precise results with minimum errors.

Growth in these target markets of emerging nations will likely open a foray of opportunities for players operating in the lab automation market soon.

CHALLENGES: Issues related to system integration

The major difficulty in lab automation arises with system integration, which mainly happens due to the integration challenges from disparate technologies and legacy systems, which are not easily integrated into modern automated configurations. When new technologies are being incorporated into an existing laboratory setup, problems occur due to the lack of effective communication of older hardware and software platforms with advanced automation tools. Laboratories typically have many instruments and data management systems, all of which are proprietary systems with unique protocols and formats, and interoperability is a persistent problem. Non-seamless integration leads to delays, error-prone data, and costly customizations to make different systems work together; hence, the potential benefits from automation in terms of greater efficiency, accuracy, and throughput are quite often nullified. Integration processes are followed by calibration, validation, and downtime, which may further prolong the implementation time cycle and cost, especially if specialty expertise is involved. It takes strategic planning in most cases in the form of customized solutions to maintain a lab automation system in an integrated, efficient, and compliant state. Further, training of the personnel is also required to successfully integrate automation solutions into the existing devices.

Global Lab Automation Market Ecosystem Analysis

The Lab Automation market ecosystem includes various products and applications. Lab Automation products manufacturers focus on automated workstations, off-the-shelf automated work cells, software, robotic systems and automated storage & retrieval systems. These products have applications in drug discovery, diagnostics, proteomics, genomics, and microbiology. Other than this, the end users comprise hospitals and diagnostic centers, pharmaceutical and biotechnology companies, academic institutes, forensic labs, environment testing labs, and the food & beverage industry.

Lab Automation Market
 

Automated workstation to register largest market share in 2024

The global market of lab automation is expected to be dominated by automated workstations in 2023, mainly because these play a very important role in the increase of productivity and accuracy in labs. Such workstations essentially automate everything from sample preparation to data analysis and liquid handling processes, which provide crucial efficiency and reliability. These types of automated workstations will be most valuable in sectors like pharmaceuticals, biotechnology, and clinical diagnostics. The growing requirement of high-throughput, error-free workflows in drug discovery, genomics, and so on has increased the demand even more because automated workstations reduce the labor of individuals largely streamlining processes. Hence, they are largely used by prominent companies. For example, the Fluent Liquid Handler provided by Tecan Group (Switzerland) helps in quicker and more precise liquid handling. It is integrated with 1 to 3 robotic arms, and it can perform tasks such as pipetting, tip ejection, and gripping. In addition, the integration of robotics and software advancements into laboratories has improved workstation capabilities. It has enabled laboratories to meet stringent regulatory requirements more effectively with optimal complex testing workflows.

Drug Discovery to register the largest share during the forecast period

The year 2023 saw the emergence of drug discovery as the dominant segment in the lab automation market, which is the pharmaceutical industry's quest for efficient, high-throughput screening solutions. Automation has significantly reduced manual labor at critical stages of drug discovery, including compound screening, lead optimization, and assay development, thereby accelerating workflows and improving precision. A high throughput of sample volumes with accuracy and consistency is the only way to do rapid identification of viable drug candidates at an affordable cost. The rising investment in the novel therapeutic areas of oncology, infectious diseases, and neurological disorders is pushing pharmaceutical companies to adopt automation for efficient workflow, improved data accuracy, and strict regulatory compliance. Automation technology is successfully used by key players for drug discovery. For instance, The LINQ platform from Automata (UK) assists in drug discovery procedures such as assays and tissue culture. This further supported the growth of this segment within the lab automation market.

Hospitals and Diagnostic Laboratories hold the largest share of the end-user market during the forecast period

In 2023, the hospital and diagnostic laboratory segment showed the largest share in the market. This is caused by the increasing demand for high-throughput, efficient solutions necessary for handling large volumes of samples and testing complexity. To the extent of improving workflow efficiency and reducing human errors, with instant and precise diagnostic result availability, automation has importance. This transformation benefits, in addition to the betterment of patient care outcomes, reflect a very considerable role of automation. Technologies like sample handling systems and data management platforms allow these laboratories to carry out a high volume of tests with improved accuracy hence supporting better patient care.

US to account for a significant market share in the Lab Automation market

In North America, the lab automation market will be primarily dominated by the US during the forecast period. This is largely due to various key factors such as the presence of pharma and biotech companies in the region. In January 2023, Agilent Technologies (US) invested USD 725 million to expand its therapeutic nucleic acid producing capacity. Besides these, the growing demand to have more efficient laboratory operations in the management of enhanced volumes of diagnostic tests, as well as drug development, is fueling the market growth. Additionally, the supportive initiatives of the U.S. government toward healthcare innovation as well as the adoption of more enhanced technologies in healthcare have paved the way for the greater intake of automated systems, consequently increasing productivity and precision levels. Moreover, the smooth acceptance of new technologies including artificial intelligence and robotics has further supported the position of the U.S. lab automation market. The U.S. will be the leading nation even in the future since more operational efficiency and shorter turnaround times will be achieved.

HIGHEST CAGR MARKET IN 2024-2030
CHINA FASTEST GROWING MARKET IN THE REGION
Lab Automation Market

Recent Developments of Lab Automation Market

  • In July 2023, Tecan Group (Switzerland) collaborated with Singular Genomics Systems, Inc., (US) to design customized reagent kits for the NGS library preparation system, in a bid to streamline efficiency and workflow optimization in genomics research.
  • In February 2023, Tecan (Switzerland) collaborated with Element Biosciences, Inc., (US) by combining Tecan's automation solutions with the advanced sequencing techniques offered by Element.
  • In 2023, Danaher Corporation (US) acquired Abcam plc (UK) to mark its presence in the proteomics sector. The deal size was USD 5.60 Billion
  • In April 2022, Revvity, Inc. (US) collaborated with Scitera Corporation (US) to create a new lab model that advances lab automation by improved management of data and collaboration of scientists from multiple disciplines.

Key Market Players

KEY PLAYERS IN THE LAB AUTOMATION MARKET INCLUDE

  • Revvity (US)
  • Eppendorf AG (Germany)
  • Becton, Dickinson and Company (US)
  • Waters Corporation (US)
  • Siemens Healthineers (Germany)
  • Abbott Laboratories (US)
  • Biomérieux (France)
  • Hamilton Company (US)
  • Hudson Robotics (US)

Want to explore hidden markets that can drive new revenue in Lab Automation Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million/USD Billion)
Segments covered Product, Application, End User, and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

 

Key Questions Addressed by the Report

What will be the addressable market value of the global Lab Automation market within five years?
The global Lab Automation market is projected to reach USD 7.71 billion by 2029 from USD 5.85 billion in 2024, at a CAGR of 6.9%.
Which product type segments have the highest potential for growth in the Lab Automation market?
Automated workstations are expected to exhibit the highest growth rates.
Who are the top 3 players in the market, and how is market share distributed among them?
The leading players are F. Hoffmann-La Roche (share: 26-31%), Tecan Group (share: 10-15%), and Danaher (share: 5-10%). Other players hold 35-40% of the market share.
What are the major strategies adopted by leading players to enter emerging regions?
Distribution agreements, partnerships, product launches, and product approvals are the major growth strategies adopted by leading market players.
What are the emerging trends in the global Lab Automation market?
The wave of lab automation involves AI and machine learning for optimizing analysis and predictive modeling of data. There is increased use of robotic systems for high-throughput screening, miniaturized and microfluidic devices that offer cheaper, more accurate, and efficient laboratory practices.
What are the major factors likely to hamper the growth of the Lab Automation market?
The complicated integration of automation technology, stringent regulations, and the high initial cost of products can hamper market growth.
Which end-user segment will likely show the highest growth in the Lab Automation market?
Hospitals and diagnostic laboratories are expected to grow at the highest rate in the end-user segment.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Lab Automation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
1
RESEARCH METHODOLOGY
34
EXECUTIVE SUMMARY
65
PREMIUM INSIGHTS
78
MARKET OVERVIEW
98
  • 5.1 MARKET DYNAMICS
    DRIVERS
    RESTRAINTS
    KEY GROWTH OPPORTUNITIES
    INDUSTRY-SPECIFIC CHALLENGES
  • 5.2 PORTER’S FIVE FORCES ANALYSIS
  • 5.3 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANISATIONS
    REGULATORY TRENDS, BY REGION
  • 5.4 ECOSYSTEM MARKET MAP
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
    AVERAGE SELLING PRICE TREND, BY REGION
  • 5.8 PATENT ANALYSIS
  • 5.9 TRADE ANALYSIS
  • 5.10 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Cobots
    - Microfluidics Technology
    - High-Throughput Screening (HTS) Technologies
    COMPLIMENTARY TECHNOLOGIES
    - Cloud Connectivity
    - Internet of Things (IoT)
    - Digital Twins
    ADJACENT TECHNOLOGIES
    - Biobanking
    - Automated Research Instruments
  • 5.11 KEY CONFERENCES & EVENTS IN 2024-2025
  • 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN THE BUYING PROCESS
    BUYING CRITERIA
  • 5.14 UNMET NEEDS/END USER EXPECTATIONS IN LAB AUTOMATION MARKET
  • 5.15 INVESTMENT AND FUNDING SCENARIO
  • 5.16 IMPACT OF AI IN THE LAB AUTOMATION MARKET
LAB AUTOMATION MARKET, BY PRODUCT (USD MILLION; 2022—2029)
116
  • 6.1 INTRODUCTION
  • 6.2 AUTOMATED WORKSTATIONS
    AUTOMATED LIQUID HANDLING SYSTEMS
    - Automated integrated workstations
    - Pipetting systems
    - Reagent dispensers
    - Microplate washers
    MICROPLATE READERS
    - Multi-mode microplate readers
    - Single-mode microplate readers
    AUTOMATED ELISA SYSTEMS
    AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS
  • 6.3 OFF-THE-SHELF AUTOMATED WORK CELLS
    PRE-ANALYTICAL AUTOMATION
    POST-ANALYTICAL AUTOMATION
    TOTAL LAB AUTOMATION
  • 6.4 SOFTWARE
    LABORATORY INFORMATION MANAGEMENT SYSTEMS
    ELECTRONIC LABORATORY NOTEBOOKS
    LABORATORY EXECUTION SYSTEMS
    SCIENTIFIC DATA MANAGEMENT SYSTEMS
  • 6.5 ROBOTIC SYSTEMS
    ROBOTIC ARMS
    TRACK ROBOTS
    COLLABORATIVE ROBOTS
    MOBILE ROBOTS
  • 6.6 AUTOMATED STORAGE & RETRIEVAL SYSTEMS
  • 6.7 OTHER LAB AUTOMATION EQUIPMENT
LAB AUTOMATION MARKET, BY APPLICATION (USD MILLION; 2022—2029)
156
  • 7.1 INTRODUCTION
  • 7.2 DRUG DISCOVERY
    HIGH-THROUGHPUT SCREENING
    COMPOUND MANAGEMENT
    ADME SCREENING
    COMPOUND WEIGHING & DISSOLUTION
    OTHER DRUG DISCOVERY APPLICATIONS
  • 7.3 DIAGNOSTICS
    PRE-ANALYTICS/SAMPLE PREPARATION
    ENZYME IMMUNOASSAYS
    SAMPLE DISTRIBUTION, SPLITTING, AND ARCHIVING
  • 7.4 GENOMICS
  • 7.5 PROTEOMICS
  • 7.6 MICROBIOLOGY
  • 7.7 OTHER APPLICATIONS
LAB AUTOMATION MARKET, BY END-USERS (USD MILLION; 2022—2029)
167
  • 8.1 INTRODUCTION
  • 8.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
  • 8.3 HOSPITAL & DIAGNOSTIC LABORATORIES
  • 8.4 RESEARCH & ACADEMIC INSTITUTES
  • 8.5 ENVIRONMENTAL TESTING LABORATORIES
  • 8.6 FORENSIC LABORATORIES
  • 8.7 FOOD & BEVERAGE INDUSTRY
LAB AUTOMATION MARKET, BY REGION (USD MILLION; 2022—2029)
198
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    CANADA
  • 9.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    FRANCE
    UK
    ITALY
    SWITZERLAND
    NETHERLANDS
    REST OF EUROPE
  • 9.4 ASIA-PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA-PACIFIC
    CHINA
    JAPAN
    INDIA
    AUSTRALIA
    SOUTH KOREA
    REST OF ASIA-PACIFIC
  • 9.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    MEXICO
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    REST OF MIDDLE EAST AND AFRICA
COMPETITIVE LANDSCAPES
213
  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN (2021-2024)
  • 10.3 REVENUE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS BY KEY PLAYERS, 2023
    LAB AUTOMATION MARKET
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - COMPANY FOOTPRINT
    - REGION FOOTPRINT
    - PRODUCT FOOTPRINT
    - APPLICATION FOOTPRINT
    - END-USER FOOTPRINT
  • 10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - DETAILED LIST OF KEY STARTUPS/SMES
    - COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 10.7 C0OMPETITIVE SITUATION AND TRENDS (2021-2024)
    NEW PRODUCT LAUNCHES & APPROVALS
    DEALS
    OTHER DEVELOPMENTS
  • 10.8 BRAND/PRODUCT COMPARATIVE ANALYSIS PRODUCT COMPARISON
  • 10.9 COMPANY VALUATION AND FINANCIAL METRICS
COMPANY PROFILES**
226
  • 11.1 KEY PLAYERS
    THERMO FISHER SCIENTIFIC
    TECAN GROUP
    DANAHER CORPORATION
    AGILENT TECHNOLOGIES
    F. HOFFMANN-LA ROCHE LTD.
    REVVITY
    EPPENDORF AG
    BECTON, DICKINSON AND COMPANY
    WATERS CORPORATION
    SIEMENS HEALTHINEERS
    ABBOTT LABORATORIES
    BIOMÉRIEUX
    HAMILTON COMPANY
    HUDSON ROBOTICS
  • 11.2 OTHER PLAYERS
    GILSON, INC.
    BMG LABTECH
    FESTO AG & CO. KG
    AURORA BIOMED INC.
    HIGHRES BIOSOLUTIONS
    OPENTRONS LABWORKS INC.
    PEAK ANALYSIS AND AUTOMATION
    QIAGEN N.V.
    LABVANTAGE SOLUTIONS, INC.
    BIO-RAD LABORATORIES, INC.
    LABWARE
    SYSMEX CORPORATION
    UNIVERSAL ROBOTS
    AB CONTROLS, INC.
    AUTOMATA
    SPT LABTECH
APPENDIX
237
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

 

Four primary studies have been undertaken to size the lab automation market. Secondary research has been used to obtain preliminary data for the lab automation market and peer and parent markets. Data were collected from 3-5 secondary sources, and validated by primary sources for assumptions and market sizing. Through top-down and bottom-up approaches, the overall market size was informed and further broken down, and data was triangulated for segment and subsegment sizing.

Secondary Research

These included directories, Factiva, white papers, Bloomberg Businessweek, annual reports, SEC filings, business filings, and investor presentations, among others Through these souces, one can gain critical data about market leaders, how the industry is divided into sectors, and how technology varies from one industry level to another within lab automation.

Primary Research

Primary research consisted of interviewing people from the supply side of the business and the demand side to get quantitative and qualitative insights. On the demand side, primary sources involved in the study included physicians, researchers, department heads, staff from diagnostic centers, hospital staff, and those attached to the research institutes, while on the supply side, it involved CEOs, area sales managers, territory and regional sales managers, and various other top executives of relevant companies. These direct meetings with people in key leadership positions helped validate assumptions arising from secondary research and bring them face-to-face so that any assumptions could also be directly questioned.

A breakdown of the primary respondents is provided below:

Lab Automation Market

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The revenue share analysis of major companies was used in this report to determine the size of the global lab automation market. This was accomplished by identifying the major market participants and calculating their lab automation business revenues using a variety of information acquired throughout the primary and secondary research stages. Examining the annual and financial reports of the leading market participants was one aspect of secondary research. On the other hand, primary research involved in-depth interviews with important thought leaders, including directors, CEOs, and important marketing executives.

Segmental revenues were computed using the revenue mapping of the leading solution/service providers to determine the worldwide market value. The following steps were engaged in this process:

  • Making a list of the leading international companies in the lab automation industry
  • Charting the annual profits made by the leading companies in the lab automation sector (or the closest stated business unit/product category)
  • As of 2023, revenue mapping of leading companies to cover a significant portion of the global market
  • Calculating the lab automation industry's global value

Global Lab Automation Market: Bottom-up and Top-down approach

Lab Automation Market

Data Triangulation

The above process has divided the Lab Automation market into several segments and subsegments. Then, data triangulation and the market segmentation process are conducted to confirm the accuracy of the data for each segment. Both factors and trends from the demand and supply sides were researched. Top-down and bottom-up approaches yield the outcome from the analysis of the Lab Automation market.

Market Definition

The lab automation market includes automated workstations, off-the-shelf automated work cells, robotics, automated storage & retrieval systems, and software to automate laboratory procedures and boost efficiency, productivity, and accuracy. It is integrated with devices to aid in complicated operations, data collection, and repetitive procedures occurring in life sciences, academic institutes, diagnostics, pharmaceutical research, and other labs. Drug discovery, diagnostics, proteomics, genomics, and microbiology are some of the most critical applications of lab automation solutions.

Stakeholders

  • Lab automation solution manufacturers, suppliers, and providers
  • Lab automation equipment and software solution providers
  • Lab automation integrated solution providers
  • Academic institutions and private research institutions
  • Environmental testing laboratories
  • Food & beverage testing centers
  • Hospitals and diagnostic centers
  • Forensic laboratories
  • CROs and CDMOs
  • Pharmaceutical & biopharmaceutical companies
  • Consulting firms

Report Objectives

  • To define, describe, and forecast the lab automation market based on product, application,
    end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their market ranking and core competencies2
  • To benchmark players within the market using a proprietary competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business strategy excellence and strength of product portfolio
  • To track and analyze competitive developments such as product launches, agreements, expansions, collaborations, and acquisitions in the lab automation market

Previous Versions of this Report

Lab Automation Market by Product (Robotic Arm, Microplate Readers, Workstation, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics, Proteomics, Microbiology), End-User (Pharma, Diagnolab, Forensics, Environmental) - Global Forecast to 2028

Report Code AST 5764
Published in Feb, 2023, By MarketsandMarkets™

Lab Automation Market by Product (Robotic Arm, Microplate Readers, Workstation, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics, Proteomics, Microbiology), End-User (Pharma, Diagnolab, Forensics, Environmental) - Global Forecast to 2025

Report Code AST 5764
Published in Nov, 2020, By MarketsandMarkets™

Lab Automation Market by Equipment and Software (Robotic Arms, Microplate Readers, LIMS), Applications (Drug Discovery, Clinical Diagnostics, Genomics), End Users (Biotechnology and Pharmaceuticals, Diagnostic Labs) - Global Forecast to 2022

Report Code MD 3365
Published in Nov, 2017, By MarketsandMarkets™

Lab Automation Market by Equipment & Software (Robotic Arm, Microplate Readers, LIMS), Applications (Drug Discovery, Clinical Diagnostics), Type (Modular, Total Lab), & End Users (Biotechnology & Pharmaceuticals, Private Labs) - Global Forecasts to 2021

Report Code MD 3365
Published in Oct, 2016, By MarketsandMarkets™

Lab Automation Market by Equipment & Software (Robotic Arm, Microplate Readers, LIMS), Applications (Drug Discovery, Clinical Diagnostics), Type of Automation (Modular, Total Lab), & End Users (Biotechnology & Pharmaceuticals) - Global Forecasts to 2020

Report Code MD 3365
Published in Apr, 2015, By MarketsandMarkets™

Lab Automation Market by Equipment & Software (Robotic Arm, Microplate Readers, LIMS), Applications (Drug Discovery, Clinical Diagnostics), Type of Automation (Modular, Total Lab), & End Users (Biotechnology & Pharmaceuticals) - Global Forecasts to 2020

Report Code MD 3365
Published in Jan, 2011, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Lab Automation Market

DMCA.com Protection Status